September 2025 in “American Journal of Dermatopathology” In this report, a unique case of lupus panniculitis of the scalp was diagnosed in a 40-year-old woman presenting with non-scarring patchy alopecia, which responded completely to oral prednisolone and methotrexate treatment.
June 2025 in “Academic Medical Journal” This study suggests elevated homocysteine levels may serve as a biomarker for disease severity and vascular risk in cutaneous lupus erythematosus, indicating potential therapeutic benefits from B-vitamin supplementation and lifestyle changes.
May 2025 in “The Journal of Rheumatology” This case report from BIRDEM General Hospital describes a 17-year-old girl with systemic lupus erythematosus who developed a rare form of lupus enteritis affecting her colon and rectum. Her symptoms improved significantly after treatment with corticosteroids and immunosuppressants.
April 2025 in “Dermatología Argentina” This study found that simultaneous presence of specific and nonspecific skin lesions, or having three or more types of skin lesions, was associated with increased systemic activity of systemic lupus erythematosus.
November 2024 in “International Medical Case Reports Journal” Glucocorticoid treatment in lupus can cause oral lesions, which need early diagnosis and comprehensive care.
October 2024 in “Journal of Case Reports in Medical Science” This case report describes a woman whose psychiatric symptoms preceded the clear signs of systemic lupus erythematosus, which could suggest they were early indicators of SLE or related to an underlying mental disorder exacerbated by SLE.
October 2024 in “Heliyon” This case report identified a connection between idiopathic intracranial hypertension, papilledema, and newly diagnosed systemic lupus erythematosus in a young woman, highlighting the importance of thorough system reviews in such circumstances.
September 2024 in “International Journal of Innovative Science and Research Technology (IJISRT)” This case report describes a 32-year-old woman with Systemic Lupus Erythematosus who developed severe lupus nephritis, emphasizing that early diagnosis and aggressive immunosuppressive therapy significantly improved her condition and reduced proteinuria, underscoring the importance of prompt treatment to prevent irreversible kidney damage.
July 2024 in “Clinical Case Reports” In this case study, a 25-year-old presented with symptoms of lupus but tested negative for antinuclear antibodies, complicating diagnosis. The researchers emphasize that comprehensive diagnostic approaches, beyond ANA testing, are vital for effectively identifying and treating lupus nephritis to avoid serious outcomes.
June 2024 in “Research Square (Research Square)” This study found that among patients with systemic lupus erythematosus, the absence of skin rash and low levels of complement C3 were significant risk factors for developing lupus nephritis, with their combination demonstrating good predictive diagnostic value.
April 2024 in “JMIR infodemiology” This study found that TikTok provides valuable insights into experiences with lupus erythematosus, highlighting distress from symptoms, negative perceptions of pharmacologic treatments, and issues with feeling "medically gaslighted.
March 2024 in “Intisari Sains Medis” This study highlights that juvenile SLE patients, particularly with lupus nephritis and critical conditions, may have a higher risk of thyroid dysfunction and low FT4, potentially worsening their prognosis.
January 2024 in “Revista Dermatológica Centro Uraga” This case report describes a 68-year-old woman diagnosed with chronic cutaneous lupus, characterized by irregular plaques with distinct pigmentation and scarring alopecia, confirmed through histopathology revealing specific skin changes.
December 2023 in “Journal of General Procedural Dermatology and Venereology Indonesia” The abstract highlights that lichen planus can manifest as cicatricial alopecia or lichen planopilaris, while discoid lupus erythematosus, a common form of lupus erythematosus, typically causes scarring alopecia. Results are not reported here.
December 2023 in “Curēus” In this case study, a 36-year-old female with severe lupus enteritis and intestinal pseudo-obstruction showed significant clinical improvement after treatment with intravenous methylprednisolone, hydroxychloroquine, and cyclophosphamide, highlighting the complexities and challenges in diagnosing and managing atypical lupus manifestations.
August 2023 in “Annales de Dermatologie et de Vénéréologie” This study provides an updated overview of non-scarring alopecia in lupus erythematosus patients, revealing that diffuse/patchy NSA and lupus hair are strongly associated with systemic activity and respond well to SLE therapy, while progression to scarring alopecia was rare.
This study used TikTok videos to explore experiences of individuals with lupus erythematosus, revealing that mucocutaneous symptoms significantly impact mental health and body image, while pharmacologic treatments are often viewed negatively, leading to important implications for clinical interactions and validation.
In this study, Korean patients with systemic lupus erythematosus had a worse perception of the COVID-19 vaccine compared to the influenza vaccine, with higher reported adverse events and concerns about causing lupus flares.
April 2023 in “Research Square (Research Square)” This study found that lower GPX4 mRNA levels in polymorphonuclear neutrophils of systemic lupus erythematosus patients were negatively associated with disease activity and serological markers, suggesting a diagnostic value for GPX4 mRNA.
October 2021 in “European journal of cancer” This case report describes a rare coexistence of primary subcutaneous panniculitis-like T-cell lymphoma and lupus panniculitis in a 20-year-old Moroccan woman, highlighting the importance of repeated biopsies for accurate diagnosis in resistant cases.
September 2021 in “CRC Press eBooks” This chapter discusses specific types of alopecia associated with lupus erythematosus, attributing hair loss primarily to inflammatory processes but reports no new clinical results.
May 2021 in “Biomedical Journal of Indonesia” This case report describes a 20-year-old man diagnosed with Systemic Lupus Erythematosus and lupus hepatitis, who presented with joint pain and skin symptoms and was treated with methyl prednisolone and hydroxychloroquine.
April 2021 in “Bioscientia Medicina Journal of Biomedicine and Translational Research” This report describes a severe COVID-19 case in a patient with SLE and nephritis, where hydroxychloroquine improved outcomes after regular use.
This case report describes a 21-year-old woman with systemic lupus erythematosus who developed lupus nephritis in the context of thrombotic microangiopathy, including a rare presentation of cryoglobulin-like thrombi.
January 2020 in “Clinical Case Reports and Reviews” This study observed that the coexistence of Frontal Fibrosing Alopecia and lupus erythematosus in a patient may suggest a shared pathogenic background.
This case report details a child with a specific TNFAIP3 mutation manifesting as a severe SLE/SS phenotype, expanding the known phenotype for this genetic variant.
July 2018 in “IP Indian Journal of Clinical and Experimental Dermatology” This case report describes a 52-year-old male with folliculitis decalvans, initially resembling lupus vulgaris, who was successfully treated with minocycline and clarithromycin.
November 2013 in “Dalhousie Medical Journal” This review discusses the epidemiology and cutaneous manifestations of lupus erythematosus, highlighting comparable incidence rates between cutaneous and systemic forms, but reports no new findings.
September 2012 in “Turkish Journal of Dermatology” In this case report, a 17-year-old with systemic lupus erythematosus showed improvement in erythema multiforme-like lesions after treatment with methylprednisolone.
January 2010 in “DOAJ (DOAJ: Directory of Open Access Journals)” This study concluded that monthly pulse IV cyclophosphamide is effective for severe lupus nephritis in Indian patients, achieving complete or partial remission in 68.9% of cases, though longer follow-up is needed.